Otsuka Holdings Co., Ltd.

4578.T
Drug Manufacturers - General
2026/03/03 Updated
Market Cap: $35.3B (¥5.5T)
Stock Price: $66.85 (¥10,445)
Exchange Rate: 1 USD = ¥156.25

Notice Regarding the Status of Treasury Stock Acquisition

From February 16 to February 27, 2026, we acquired 312,900 shares of our common stock through market purchases at a total amount of 3,295,727,500 yen.

Importance:
Page Updated: March 2, 2026
IR Disclosure Date: March 2, 2026

Key Figures

  • Number of shares acquired: 312,900 shares
  • Total acquisition cost: 3,295,727,500 yen
  • Acquisition period: 2026-02-16 to 2026-02-27

AI要約

Overview of Treasury Stock Acquisition

Otsuka Holdings Co., Ltd. acquired 312,900 shares of its common stock through market purchases between February 16 and February 27, 2026, based on the Board of Directors resolution dated February 13, 2026. The total acquisition cost was 3,295,727,500 yen. The method of acquisition was market purchase on the Tokyo Stock Exchange.

Details of Board Resolution and Cumulative Acquisition Status

The Board resolution set the upper limit for shares to be acquired at 7 million shares, the upper limit for acquisition cost at 50 billion yen, and the acquisition period from February 16 to December 23, 2026. As of February 28, 2026, a cumulative total of 312,900 shares have been acquired at a total cost of 3,295,727,500 yen.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.